Valacyclovir: all 95 studies that test it
Page 1 of 1. Open to participants first (10), then studies with results posted, then the rest; newest registration first within each.
- SARS-CoV-2 and Herpesvirus Inhibition for Ending Long COVID DysfunctionNot yet recruitingNCT07597902Phase 2
- Oral Herpesviruses and Oral Mucositis in Patients Receiving Head and Neck RadiotherapyEnrolling by invitationNCT07363031Phase 2
- Study of an AAV Mediated Dual-Payload Gene Therapy in Patients With High Grade GliomaRecruitingNCT07346144Phase 1/2
- A Biomarker Study in Men With Localized Prostate Cancer Treated With Aglatimagene BesadenovecRecruitingNCT07332000Phase 2
- Is Valacyclovir Non-inferior to Valganciclovir as CMV and EBV Prophylaxis in Kidney Transplant Recipients? A Single-Center Prospective Randomized Pilot StudyRecruitingNCT07294547Not applicable
- Virus-Based Gene Therapy (AdV-HSV1-TK and AdV-Flt3L) in Combination With Valacyclovir for the Treatment of Pediatric and Young Adult Patients With Resectable, Recurrent Primary Malignant Brain TumorsRecruitingNCT06914479Phase 1
- Valacyclovir Monotherapy in Pain Management of Acute Periapical Abscesses After Emergency Chamber OpeningRecruitingNCT06344195Phase 4
- The Efficacy of Systemic Valacyclovir (Valtrex) on PeriodontitisRecruitingNCT05712343Early Phase 1
- VZV in the Enteric Nervous System: Pathogenesis and ConsequencesRecruitingNCT05550194Phase 4
- Valacyclovir in Pain Management of Acute Apical AbscessesRecruitingNCT05266040Phase 2
- Neonatal Phase 1 Valacyclovir StudyCompletedNCT05468619Phase 1Results posted
- Valacyclovir for Mild Cognitive ImpairmentCompletedNCT04710030Phase 2Results posted
- Valacyclovir in Neonatal Herpes Simplex Virus DiseaseCompletedNCT04448392Phase 1Results posted
- Anti-viral Therapy in Alzheimer's DiseaseCompletedNCT03282916Phase 2Results posted
- Zoster Eye Disease StudyCompletedNCT03134196Phase 4Results posted
- ValGanciclovir Versus ValAcyclovir for Viral Prophylaxis in Kidney TransplantationCompletedNCT01972035Phase 2Results posted
- Phase III Study of ASP2151 in Herpes Zoster PatientsCompletedNCT01959841Phase 3Results posted
- Safety and Efficacy Comparator Trial of a New Drug Against Genital HerpesTerminatedNCT01658826Phase 2Results posted
- Herpes Simplex Type 1 Suppression in Hepatitis CCompletedNCT01580995Phase 2Results posted
- Evaluating Three Grams Daily Valacyclovir in Patients With Chronic Hepatitis C and HSV-2 Infection (Phase I)CompletedNCT01453075Phase 1Results posted
- Randomized Trial to Evaluate Suppressive Effect of High-Dose Valacyclovir Versus Once-Daily Valacyclovir on Persons With HSV-2CompletedNCT01346475Phase 4Results posted
- Valacyclovir 1000 mg Tablet Under Fed ConditionsCompletedNCT01149460Phase 1Results posted
- Valacyclovir vs. Acyclovir as HSV-2 Suppressive Therapy: Effect on Plasma HIV-1 Levels Among HIV-1/HSV-2 Co-infected PersonsCompletedNCT01026454Phase 4Results posted
- Effect of Valacyclovir in the Reduction of HSV-2 Recurrence and SheddingCompletedNCT00803543Not applicableResults posted
- Phase 2a Study of CAN-2409 With Standard Radiation Therapy for Malignant GliomaCompletedNCT00589875Phase 2Results posted
- HSV-2 Suppression to Reduce Maternal HIV-1 RNA Levels During Pregnancy and BreastfeedingCompletedNCT00530777Phase 2Results posted
- Trial to Study the Effect of Dose of Herpes Simplex Virus-2 (HSV-2) Suppressive Therapy on HSV and HIVCompletedNCT00527618Phase 4Results posted
- Systematic Evaluation of Antiviral Medication in SchizophreniaCompletedNCT00514449Phase 2Results posted
- Research Study of Bipolar Mood Symptoms and Cognitive ProblemsCompletedNCT00428298Phase 2Results posted
- VALTREX(Valacyclovir) Once Daily for Viral Shedding In Subjects Newly Diagnosed With HSV-2CompletedNCT00306293Phase 4Results posted
- A Study Comparing Daily Treatment With Valaciclovir To Placebo For Suppression Of Herpes Simplex Virus HSV-2 Genital Herpes In Newly Diagnosed Patients. VALTREX® Tablet is a Trademark of the GlaxoSmithKline Group of Companies.CompletedNCT00158860Phase 4Results posted
- VALTREX Once Daily For Viral Shedding In Herpes Simplex Virus 2 (HSV-2) Seropositive Subjects. VALTREX® Tablet is a Trademark of GlaxoSmithKline Group of Companies.CompletedNCT00116844Phase 4Results posted
- Long Term Treatment of Herpes Simplex Encephalitis (HSE) With ValacyclovirCompletedNCT00031486Phase 3Results posted
- Effect of Valaciclovir on Inter-Appointment Pain in Endodontic Treatment of Necrotic TeethCompletedNCT07014397Not applicable
- Using Oral Valacyclovir to Treat Patients With Refractory IC/BPSStatus unknownNCT05094414Phase 1
- Pharmacokinetics of Valacyclovir Oral Solution in ChildrenTerminatedNCT04081480Not applicable
- Epstein-Barr Virus Suppression in Chronic Obstructive Pulmonary Disease (EViSCO): a Phase 2 Randomised Control TrialTerminatedNCT03699904Phase 2
- Phase II High Risk Prostate Cancer Trial Using Gene & Androgen Deprivation Therapies, Radiotherapy, & SurgeryStatus unknownNCT03541928Phase 2
- Intratumoral Gene Mediated Cytotoxic Immunotherapy in Patients With Resectable Non-Small Cell Lung CancerCompletedNCT03131037Phase 1
- Feasibility and Effects of Valaciclovir Treatment in Persons With Early Alzheimer's DiseaseCompletedNCT02997982Phase 2
- Should We Use Oral Valacyclovir in Acute Herpetic Gingivostomatitis in Children?CompletedNCT02738229Phase 2
- Valacyclovir to Prevent Vertical Transmission of Cytomegalovirus After Maternal Primary Infection During PregnancyCompletedNCT02351102Phase 2/3
- Pharmacokinetic Interaction Study of Steady-state Tipranavir/Ritonavir (TPV/r) With Single-dose Valaciclovir (VAL) in Healthy VolunteersCompletedNCT02226978Phase 1
- Intrapleural AdV-tk Therapy in Patients With Malignant Pleural EffusionCompletedNCT01997190Phase 1
- Bioequivalence Study in Healthy Volunteers of a New Paediatric Formulation of ValacyclovirCompletedNCT01689285Phase 1
- Palatability Testing of a New Paediatric Formulation of ValacyclovirCompletedNCT01682109Phase 4
- CMV Modulation of the Immune System in ANCA-associated VasculitisStatus unknownNCT01633476Phase 2
- Cytomegalovirus Control in Critical CareCompletedNCT01503918Phase 2
- Phase 3 Study of ProstAtak® Immunotherapy With Standard Radiation Therapy for Localized Prostate CancerActive, not recruitingNCT01436968Phase 3
- To Rescue Cognition With ValaciclovirCompletedNCT01364792Phase 2
- A Relative Bioavailability Study of Valacyclovir Hydrochloride Tablets 1gm Under Fasting ConditionCompletedNCT01222910Not applicable
- A Relative Bioavailability Study of Valacyclovir Hydrochloride Tablets 1gm Under Fed ConditionCompletedNCT01222897Not applicable
- Can Valacyclovir Attenuate Inflammation in Antiretroviral-Treated HIV-Infected Individuals With Herpes Simplex Virus Type 2?CompletedNCT01176409Phase 3
- Valacyclovir 1000 mg Tablet Under Fasting ConditionsCompletedNCT01149499Phase 1
- Bioavailability Study of Valacycovir HCl Tablets, 1000 mg of Dr. Reddy's Under Fed ConditionCompletedNCT01136538Phase 1
- Bioavailability Study of Valacyclovir HCl Tablets, 1000 mg of Dr. Reddy's Under Fasting ConditionsCompletedNCT01136525Phase 1
- Bioequivalency Study of Valacyclovir Hydrochloride 1000 mg Under Fasting ConditionsCompletedNCT01132729Not applicable
- Bioequivalency Study of Valacyclovir Hydrochloride 1000 mg Under Fed ConditionsCompletedNCT01132716Not applicable
- An Open-label Trial of the Effect of Valacyclovir on Plasma HIV-1 Levels Among HIV-1 Seropositive and HSV-1/2 Seronegative PersonsWithdrawnNCT01059084Not applicable
- In UTERO Treatment of Cytomegalovirus Congenital Infection With ValacyclovirTerminatedNCT01037712Phase 4
- Herpes Simplex Type 2 Co-infection in Veterans With Chronic Hepatitis CStatus unknownNCT01037621Phase 1
- Examining the Ability of Herpes Simplex Virus Type 2 (HSV2) Therapy to Reduce HIV Target Cell Numbers in the CervixCompletedNCT00946556Not applicable
- Can Valacyclovir Delay the Need for Initiation of Human Immunodeficiency Virus (HIV) Treatment in HIV-infected Individuals?CompletedNCT00860977Phase 3
- Phase 1b Study of AdV-tk + Valacyclovir Combined With Radiation Therapy for Malignant GliomasCompletedNCT00751270Phase 1
- Valacyclovir Suppression to Improve the Stability of Vaginal Flora Among HSV-2 Seropositive WomenWithdrawnNCT00682721Not applicable
- Study to Compare Efficacy of Topical ARYS-01 (Sorivudine) Cream 3%, Oral Valaciclovir and Combination ARYS-01 Cream 3%/Oral Valaciclovir for Treatment of Herpes Zoster (Shingles)Status unknownNCT00652184Phase 2
- Fed Study of Valacyclovir Hydrochloride Tablets 1000 mg and Valtrex® Tablets 1000 mgCompletedNCT00650494Phase 1
- Fasting Study of Valacyclovir Hydrochloride Tablets 1000 mg and Valtrex® Tablets 1000 mgCompletedNCT00649974Phase 1
- Food Study of Valacyclovir Hydrochloride Tablets 1000 mg to Valtrex® Tablets 1000 mgCompletedNCT00649870Phase 1
- AdV-tk Therapy With Surgery and Chemoradiation for Pancreas Cancer (PaTK01)CompletedNCT00638612Phase 1
- A Phase I Study of AdV-tk + Prodrug Therapy in Combination With Radiation Therapy for Pediatric Brain TumorsCompletedNCT00634231Phase 1
- 30-Day Trial of Oral Valtrex or Valtrex Plus Aspirin on Shedding of HSV DNA in Tears and Saliva of VolunteersStatus unknownNCT00587496Phase 1
- Oral Valganciclovir Versus ValacyclovirCompletedNCT00562770Phase 2
- Scandinavian Bell's Palsy StudyCompletedNCT00510263Phase 4
- HSV-2 Suppression to Reduce HIV-1 Levels in HIV-1 Co-infected PersonsCompletedNCT00465205Phase 3
- HSV-2 Suppression to Reduce HIV-1 Levels in HIV-1, HSV-2 Co-infected Men.CompletedNCT00378976Phase 3
- Pharmacokinetic Study Of Valaciclovir Hydrochloride TabletsCompletedNCT00343278Phase 4
- A Safety And Tolerability Study Of Valaciclovir Oral Suspension In Infants And ChildrenCompletedNCT00297206Phase 1
- Valacyclovir+Temovate Gel for the Treatment of Herpes LabialisCompletedNCT00297011Phase 2
- Controlled Trial of Valacyclovir in Infectious MononucleosisCompletedNCT00274404Phase 1/2
- V3: Vancouver-Victoria Valacyclovir Trial for Early PsychosisCompletedNCT00175513Phase 2
- A Study of Valacyclovir to Suppress HSV and HIV Shedding in Coinfected PersonsCompletedNCT00161434Phase 4
- Randomised Controlled Trial Assessing the Impact of Genital Herpes Suppressive Therapy on HIV SheddingCompletedNCT00158509Phase 2
- A Clinical Research Study For The Suppression And Treatment Of Genital Herpes Infection In HIV-Infected PersonsTerminatedNCT00079911Phase 4
- Valacyclovir in Immunocompromised ChildrenCompletedNCT00059592Phase 1
- Valacyclovir in Preventing Cytomegalovirus Infection in Patients Who Are Undergoing Donor Stem Cell TransplantationCompletedNCT00045292Phase 3
- A Pharmacokinetic Study of Valacyclovir in Pediatric Oncology PatientsCompletedNCT00042328Phase 2
- Randomized Study of Two Doses of Oral Valacyclovir in Immunocompromised Patients With Uncomplicated Herpes ZosterCompletedNCT00006131Not applicable
- A Study of Valacyclovir as Treatment for Genital Herpes Simplex Virus in HIV-Infected PatientsStatus unknownNCT00005663Phase 3
- The Effect of Valacyclovir on the Detection of HIV From Genital Herpes Lesions in HIV-Infected PatientsCompletedNCT00002404Not applicable
- A Comparative Trial of Valacyclovir Hydrochloride ( 256U87 ) and Acyclovir for the Suppression of Anogenital Herpes Infections in HIV-Infected PatientsCompletedNCT00002084Not applicable
- A Study to Compare the Efficacy and Safety of Valacyclovir Hydrochloride ( 256U87 ) Versus Acyclovir in the Treatment of Recurrent Anogenital Herpes Infections in HIV Infected PatientsCompletedNCT00002000Not applicable
- Valaciclovir to Prevent Transmission of Herpes Simplex VirusCompletedNCT00001649Phase 3
- The Safety and Effectiveness of Valacyclovir HCl in the Treatment of Herpes Simplex or Varicella/Zoster Infections in HIV-1 Infected ChildrenWithdrawnNCT00001054Phase 1
- A Study of Valacyclovir Hydrochloride in the Prevention of Life-Threatening Cytomegalovirus Disease in HIV-Infected PatientsCompletedNCT00001038Phase 3